Troponin, where do we go from here?

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

There remain some questions concerning the specifity of the troponins, especially cardiac troponin T. Nonetheless, they represent a substantial advance in both specificity for cardiac injury and improved sensitivity. Thus, it is likely that these markers will lead to the definition of new clinical syndromes by unmasking false positive elevations in MBCK and by identifying elevations indicitave of cardiac abnormalities that could not be detected by any other means. The development of new more sensitive assays should further improve our understanding of disease processes that involve the heart by allowing for more subtle abnormalities to be detected.

Original languageEnglish (US)
Pages (from-to)737-752
Number of pages16
JournalClinics in Laboratory Medicine
Volume17
Issue number4
StatePublished - 1997
Externally publishedYes

Fingerprint

Troponin T
Troponin
Assays
Wounds and Injuries

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Troponin, where do we go from here? / Jaffe, Allan S.

In: Clinics in Laboratory Medicine, Vol. 17, No. 4, 1997, p. 737-752.

Research output: Contribution to journalArticle

@article{863210e0431d442b9a614d96aaa87709,
title = "Troponin, where do we go from here?",
abstract = "There remain some questions concerning the specifity of the troponins, especially cardiac troponin T. Nonetheless, they represent a substantial advance in both specificity for cardiac injury and improved sensitivity. Thus, it is likely that these markers will lead to the definition of new clinical syndromes by unmasking false positive elevations in MBCK and by identifying elevations indicitave of cardiac abnormalities that could not be detected by any other means. The development of new more sensitive assays should further improve our understanding of disease processes that involve the heart by allowing for more subtle abnormalities to be detected.",
author = "Jaffe, {Allan S}",
year = "1997",
language = "English (US)",
volume = "17",
pages = "737--752",
journal = "Clinics in Laboratory Medicine",
issn = "0272-2712",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Troponin, where do we go from here?

AU - Jaffe, Allan S

PY - 1997

Y1 - 1997

N2 - There remain some questions concerning the specifity of the troponins, especially cardiac troponin T. Nonetheless, they represent a substantial advance in both specificity for cardiac injury and improved sensitivity. Thus, it is likely that these markers will lead to the definition of new clinical syndromes by unmasking false positive elevations in MBCK and by identifying elevations indicitave of cardiac abnormalities that could not be detected by any other means. The development of new more sensitive assays should further improve our understanding of disease processes that involve the heart by allowing for more subtle abnormalities to be detected.

AB - There remain some questions concerning the specifity of the troponins, especially cardiac troponin T. Nonetheless, they represent a substantial advance in both specificity for cardiac injury and improved sensitivity. Thus, it is likely that these markers will lead to the definition of new clinical syndromes by unmasking false positive elevations in MBCK and by identifying elevations indicitave of cardiac abnormalities that could not be detected by any other means. The development of new more sensitive assays should further improve our understanding of disease processes that involve the heart by allowing for more subtle abnormalities to be detected.

UR - http://www.scopus.com/inward/record.url?scp=0031459032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031459032&partnerID=8YFLogxK

M3 - Article

C2 - 9439882

AN - SCOPUS:0031459032

VL - 17

SP - 737

EP - 752

JO - Clinics in Laboratory Medicine

JF - Clinics in Laboratory Medicine

SN - 0272-2712

IS - 4

ER -